EP1068527A2 - Rapid method for detecting micro-organisms and evaluating antimicrobial activity - Google Patents
Rapid method for detecting micro-organisms and evaluating antimicrobial activityInfo
- Publication number
- EP1068527A2 EP1068527A2 EP99914648A EP99914648A EP1068527A2 EP 1068527 A2 EP1068527 A2 EP 1068527A2 EP 99914648 A EP99914648 A EP 99914648A EP 99914648 A EP99914648 A EP 99914648A EP 1068527 A2 EP1068527 A2 EP 1068527A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- micro
- organisms
- sample
- organism
- zeta potential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 129
- 238000000034 method Methods 0.000 title claims abstract description 85
- 230000000845 anti-microbial effect Effects 0.000 title claims description 18
- 238000005259 measurement Methods 0.000 claims abstract description 21
- 239000012530 fluid Substances 0.000 claims abstract description 16
- 230000005684 electric field Effects 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000004599 antimicrobial Substances 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 230000035945 sensitivity Effects 0.000 claims description 10
- 238000000733 zeta-potential measurement Methods 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 7
- 238000009635 antibiotic susceptibility testing Methods 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 4
- 238000012790 confirmation Methods 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 241000501458 Cultus Species 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 1
- 230000003389 potentiating effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 37
- 210000004027 cell Anatomy 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- 238000011282 treatment Methods 0.000 description 15
- 230000003115 biocidal effect Effects 0.000 description 14
- 239000002245 particle Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 13
- 239000003814 drug Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000037230 mobility Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000006193 liquid solution Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 102000006635 beta-lactamase Human genes 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000002815 broth microdilution Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000002768 Kirby-Bauer method Methods 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000005311 autocorrelation function Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- -1 brewing worts Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 208000014745 severe cutaneous adverse reaction Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002477 vacuolizing effect Effects 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2304/00—Chemical means of detecting microorganisms
- C12Q2304/80—Electrochemical detection via electrodes in contact with culture medium
Definitions
- the present invention relates to methods and apparatus for the detection of the presence of specific micro-organisms in a fluid It is particularly applicable, but in no way limited, to identifying microbial pathogens in liquid solution
- the invention also relates to methods for antibiotic sensitivity testing, and in particular methods for assessing the effectiveness of antimicrobial agents, for screening compounds for antimicrobial activity, and for determining an appropriate means of treatment for an unknown microbial infection
- micro-organism has a broad meaning It encompasses bacteria, viruses and fungi
- micro-organisms It is also known to detect micro-organisms by the use of specific probes that are designed to attach themselves to the micro-organism by covalent bonding and thus to attach a marker to them so that they may be detected by some physical property Unlike the present invention such techniques are slow and can only search for one micro-organism at a time
- antibiotic sensitivity of bacteria can be assessed in a variety of ways 1 Agar Diffusion tests, in which the antibiotic is allowed to diffuse from a point source, commonly in the form of a filter paper disc, into an agar medium which has been seeded with a test organism
- Agar incorporation tests which are essentially similar to broth dilution tests except that the antibiotic dilutions are incorporated in an agar medium in a series of Pet ⁇ dishes
- These are spot-inoculated with a number of test organisms, usually be means of a semi-automatic inoculation device
- Lead molecules are typically only weakly active, and may be toxic or otherwise unsuitable for use as drugs
- lead expansion in which hundreds or thousands of variants of the most promising leads are made These are tested, and some are typically found to be more active and/or less toxic than the original leads This process can be iterative
- combinatorial library approach is also suitable for this lead expansion phase
- a method of identifying one or more micro-organisms in a fluid comprising the steps of - (i) taking a sample of the fluid containing a representative sample of any m ⁇ cro-organ ⁇ sm(s) present, (n) optionally cultunng the sample if necessary to increase the number of micro-organisms for a pre-determined range, (MI) measuring the zeta potentials of any micro-organisms present, (iv) optionally normalising the measurements taken in step (in) such that they relate to standard conditions, (v) comparing said measured zeta potentials with a table of the zeta potentials of known micro-organisms to determine which, if any, of the known micro-organisms are present in the fluid
- a method of determining the presence of a specific micro-organism in a liquid solution which comprises applying an electric field across the solution, optically measuring the speed of movement of any micro-organism suspended in
- the measured speed of movement or electrophoretic mobility is an indication of the electro-kinetic potential, also termed zeta potential, of the micro-organism and is dependent upon several physical properties of the micro-organism including size, shape, overall charge and surface charge distribution As well as permitting a solution to be analysed for the presence of a specific micro-organism, by comparing the zeta potentials measured during analysis of a solution with a table of the zeta potentials of known micro-organisms, the invention can enable rapid analysis of a solution to determine what mixture of microorganisms are present
- an apparatus for determining the presence of a specific micro-organism in a liquid solution which comprises means for applying an electric field across a measurement cell containing the solution, a laser light source for illuminating the cell, detecting means for sensing light after impinging on a micro-organism suspended in the solution, means for analysing the scattered light to provide a measurement of the speed of movement of the micro-
- the apparatus of the invention as well as distinguishing between micro- organisms on the basis of their electo-kinetic potential, achieves improved sensitivity by allowing the scattering angle at which light is detected to be optimised for the micro-organism of interest as it has been found in practice that light from different micro-organisms is scattered in different directions
- the laser light source comprises a laser, a beam splitter for dividing the light emitted from the light source into two coherent beams, means for directing the light beams along different directions and means for modulating the length of one of the light paths to create a variable interference pattern between the two beams at the cell
- modulating the length of one of the light paths will be that the interference pattern will oscillate along the cell and light scattered by a stationary particle or micro-organism will pulsate at the frequency of the modulation If the particle is moving however, it will move with the interference in one direction and in opposition to it in the opposite direction
- the frequency of modulation of the scattered light will differ from the frequency of modulation of the length of one of the light paths by an amount indicative of the rate of movement of the particle in the cell
- the detected frequencies of light scattered by moving particles when the applied electric field is reversed should be symmetrical about the modulation frequency of the light path If, however, the electrodes of the cell are polarised then reversal of the potential applied
- the speed with which a given micro-organism will move through a solution when an electric field is applied will depend on certain factors other than the zeta potential, such as the pH and temperature of the solution It is preferred to maintain these factors constant during measurement but it is alternatively possible to measure these parameters and compensate the measurement obtained
- a method of identifying the cause of an infection in a human or animal body comprising the steps of -
- This method can be used to direct a physician to an appropriate course of treatment For example, not only can the method flag up the infecting species, but it can also list a range of possible drug treatments known to be effective against the micro-organisms which have been identified The physician would then select the appropriate treatment based on this information, the symptoms exhibited by the patient and the physicians skill and experience
- the method comprises
- the step correlating said change in zeta potential to either the antimicrobial sensitivity of a micro-organism or to the antimicrobial activity of a an antimicrobial agent may be automated
- Advantages of the present invention include avoidance of the development of drug-resistant strains, economic dispensing of medicines, and an increase in the quality of patient care
- Another object of the present invention is to provide a method for assessing emerging drugs for antimicrobial activity
- Advantages of the present invention include determination of MIC values, investigation of the effects of the candidate drugs on microbial physiology, and determination of the mechanism of action of the candidate drug
- a further object of the present invention is to provide a method for screening for agents having antimicrobial activity.
- Advantages of the present invention include the ability quickly to perform large-scale, automated screening; to identify drugs which affect cell vitality but not cell viability.
- a yet further object of the present invention is to provide an automated method for screening agents for antimicrobial activity.
- Figure 1 illustrates a stylised diagram of a yeast cell
- Figure 2 illustrates graphically the diffuse double layer around a sphere of moderate potential
- Figure 3 illustrates schematically a typical double beam apparatus for measuring zeta potentials
- Figure 4 shows the Zeta potential profile of a control sample of S pneumoniae
- Figure 5 shows the zeta potential profile of a sample of S pneumoniae treated with penicillin.
- Microelectrophoresis is a division of the science of electrophoresis and deals specifically with particles in the region of less than 20 ⁇ m and with a minimum dimension in the order of 0 01 ⁇ m Below this limit, objects are considered to be of molecular dimensions There is considerable blurring of this lower border especially when dealing with macromolecules Electrophoresis has long been the method of choice for identifying many charged molecular species, such as proteins, nucleic acid and ammo acids
- DNA finger printing which allows the separation and matching of two samples of DNA Micro-organisms of all types, from bacteria to viruses fall into the size range applicable to microelectrophoresis Viruses are particularly interesting because they are composed mostly of protein and nucleic acid and tend to have a relatively stable, uniform structure As such, they provide a direct link with conventional electrophoresis techniques When any surface is placed in contact with an aqueous solution the surface acquires a surface charge which is usually negative The origins of this are either absorption of ions from solution
- Figure 1 describes how the microorganisms can be regarded from this view point
- the shaded areas represent areas of hydrophobic surface at which charge builds up at the surface through contact absorption
- Also shown at this surface are the charges native to the surface of the micro-organism and specifically absorbed at the surface.
- the charge produces an electrical double layer and the electrical potential varies as described by Figure 2.
- Fig. 2 shows the distribution of charge across a double layer at the surface of a hypothetical micro-organism.
- the charge at the shear surface is the zeta potential; beyond this the charge decays away rapidly in the bulk solution.
- the surface charge of an idealised micro-organism arises from two sources.
- First groups on the surface of the micro-organism such as carboxylate groups, may be ionised.
- ions may be adsorbed from solution onto the surface of the micro-organism, particularly at hydrophobic regions on the surface where anionic groups may be preferentially adsorbed.
- Apparatus for measuring zeta potentials are known per se.
- One such example is the ZETASIZER 2000 (TM) made by Malvern Instruments.
- This instrument is used to measure particle size. It utilises a dual laser beam and a photodetector is arranged to measure deflected light at a fixed scattering angle.
- FIG. 3 A typical double beam instrument is shown in Figure 3 which illustrates a neon-helium laser 10 producing a red laser beam
- the beam is incident upon a beam splitter 12 that allows half the incident light energy to pass through it towards a mirror and modulator 1 and reflects the other half towards a mirror 18.
- the mirror and modulator 14 is a mirror vibrated by a piezoelectric vibrator that reflects the incident beam towards a further stationary mirror 16
- the two halves of the split laser beam are focused by a lens 20 an a cell 22 that contains a liquid to be analysed
- An electric field that is reversed periodically is applied across the cell by means of electrodes 22 and 24 and this causes micro-organisms in the liquid to move with a characteristic velocity towards the electrode that instantaneously has the opposite polarity to the net charge on the micro-organism
- the microorganism is illuminated by the laser light it scatters the incident light in a predetermined direction and this light is sensed by means of a detector 26
- the two halves of the split laser beam travel different distances before reaching the cell 20
- the path length is modulated periodically
- the two halves of the split laser interfere with one another and the interference pattern will move across the cell
- a stationary particle suspended in the cell will scatter light at a frequency related to the frequency of modulation of the mirror 14
- a particle is moving towards one end of the ceil 20 or the other, then while it is moving with the interference pattern, light scattered from it will have a lower frequency and conversely when the particle is moving in the opposite direction to the interference pattern light scattered from it will have a higher frequency
- By analysing the frequency of the scattered light sensed by the detector 26 it is possible to determine the speed and direction of movement of the particle
- the speed of movement is related to the distribution of charge about the surface of the particle and is indicative of the so-called zeta potential Depending on the shape of the particle, it will align itself differently in the applied electric field and for any specific micro-organism there will be an angle at which the intensity of the scattered light is a maximum
- the apparatus may therefore be used to determine the presence of a specific micro-organism in the solution being analysed by setting the detector 26 to the scattering angle associated with the micro-organism and monitoring the output of the detector for the frequencies corresponding to the previously determined speed of movement of the micro-organism in the applied field It is preferred to take steps to prevent polarisation of the electrodes 22, 24 as such polarisation may affect the electric field as sensed by particles suspended in the liquid in the cell 20.
- Polarisation may be prevented by pe ⁇ odically switching the polarity of the electric field. Such switching will in itself prevent polarisation but additionally it will allow polarisation to be detected as the detected frequencies will not be symmetrical about the frequency of movement of the bands of the interference pattern.
- the detector type used in this application can take a number of forms. However, we have found that commercially available solid state photodiodes such as Radio Spares Model AEPX 65 (Stock No 846/749) work well.
- the nature of the data captured takes the form of a senes of exponential decays These represent the length of time taken for the scattered light to decay to zero, this is effectively the particle velocity
- the exponential decays are converted to mean normal distributions.
- This method of handling the data measured is contained in a software programme as a means for analysing the scattered light.
- the software can contain a library or table of recorded measurements for known micro-organisms.
- a comparator programme can be run such that the operator receives as a print-out or screen message a list of those micro-organisms considered to be present
- look-up table is used as a generic term to encompass any compilation of zeta potential measurements obtained for known microorganisms.
- This look-up table can take a variety of forms. It may, for example, be a physical table whereby comparisons are made manually Alternatively, and preferably, the "table" can be a computer database of results.
- a comparator programme then compares a measured value, or series of measured values, against known results Limits may be included within the programme such that a "best fit” only answer is provided or a range of "possibilities" can be given
- the comparator programme may also advantageously contain the necessary calculations to normalise the measured zeta potential values such that they relate to standard conditions
- An apparatus of the general type described above has been used to measure the electrophoretic mobility and zeta potentials of known micro-organisms. The machine was calibrated using a standard NaCI solution having a conductivity of 0.15mS and a pH of approximately 7 0 Test samples were normalised to this conductivity by use of the B ⁇ ggs equation, which in this case takes the form
- Table II indicates that the only two members of the table that are not separable are the two members of the liste ⁇ a group of organisms.
- the elimination of the zeta potential corresponding to the micro-organism of interest is a confirmatory test if the agent is specific for the micro-organism of interest
- the agent may be an antibiotic, antibacterial or other selective poison
- the same end may also be accomplished by contacting the sample with an agent that specifically causes the agglomeration of the microorganism, such as an antibody or other immunological reagent, whereby the micro-organism is precipitated out of solution
- Dosage means to infect a solution of acid or alkali is known per se to the person skilled in the art
- Typical bases which can be used are sodium or potassium hydroxide or an amine base such as tnethylamine Acids include hydrochloric or sulphuric acid or organic acids such as acetic or citric acid.
- the apparatus may advantageously include a pH meter such that the pH of the solution in the cell is measured and recorded automatically.
- the uniformity of virus structures would give every indication that viruses can be distinguished one from another in a similar way
- this method represents an important new method of diagnosis which can be performed in vitro on a sample removed from the human body
- the method does not have to be performed by a medical practitioner but can be readily carried out by a technician.
- the technician need not have any medical knowledge in order to carry out this method effectively and requires only the most basic of training
- the method provides the medic with a clear indication of which pathogenic bacteria, or combination of bacteria, are present in the patient's sample From that information and the symptoms experienced by the patient, the medic can then formulate the most appropriate treatment It provides, in effect, an intermediate result upon which to decide on a suitable course of treatment
- the pH value of the solution and its temperature should always be the same during measurement as the pH may affect the measured zeta potential but it is alternatively possible to compensate the obtained measurement for changes in pH and temperature
- an important advantage of the present invention is that while the chemical composition of the micro-organism is the same whether it is alive or dead, the zeta potential changes when the micro-organism dies because the charge distributed around the micro-organism is affected by the chemical processes taking place while the organism is alive, especially near its outer periphery If, therefore, steps have been taken to eliminate a micro-organism that is the cause of an infection, the present invention can be used to determine if such steps have been effective
- the invention has been described in relation to identifying organisms in a solution
- the term "solution” has a very broad meaning It refers to any liquid, organic or inorganic, which may contain a micro-organism It includes, by way of example only, notionally pure water, brewing worts, body fluids such as urine and diluted samples of these, plant extracts or swabbings and solutions obtained by bubbling a gas through a liquid in order to entrain any micro-organisms present in the gas In this way contaminations in gase
- the bacterial count in the urine from patients having urinary infections is in the order of 10 6 to 10 7 cells per ml These levels are easily and rapidly detected using the method of the present invention, and it is anticipated that an indication of the infecting pathogen will be provided within 5 minutes
- Food and water samples tend to contain rather fewer bacteria per ml, and for these the sample will need to be cultured
- the sample may be mixed with, for example, McConkey's broth
- the cultured sample may be analysed for the presence or absence of micro-organisms using the method of the present invention No filtration is necessary and the broth ingredients do not interfere with the analysis
- Food samples are prepared, for example, by swabbing the surface of the food or macerating the food
- Salmonella could be detected in a chicken neck flap swab within 7h, and indications are that 200 cells per ml of Salmonella (a level which is considered to be infective) could be detected within 2 5h culture time
- this method can be applied to provide a method of antibiotic sensitivity testing
- the method comprises measuring the zeta potential of a microbial sample, which may be a known micro-organism or a clinical or veterinary sample, the sample is then exposed to an antimicrobial agent, subsequent measurement of the zeta potential indicates both the potency of the antibacterial material, and the sensitivity of the microbial sample to that material
- the approach may be applied to assessing the antimicrobial activity of a mate ⁇ al
- the material may be a compound or mixture of compounds isolated from a natural source, it may be a compound that is a derivative of a known family of antimicrobial agents, or it may be one or more compounds from a library of compounds produced by combinatorial chemistry techniques Typically these libraries contain between 5 and 50 variants of a candidate therapeutic agent
- the approach may be applied to determining the antimicrobial susceptibility of a clinical or veterinary sample obtained from a patient or animal suspected of suffering from a microbial infection to determine the most effective treatment of the infection
- the present invention is directed toward a method for assessing antimicrobial sensitivity
- the invention provides a method for rapidly assessing the susceptibility of a patient or veterinary sample to a spectrum of antimicrobial agents in order to determine the most appropriate treatment to be initiated This process could be automated, so that a patient would have a sample taken during the morning by a nurse or technician, the sample would be analysed according to the present invention, and a prescription for the most appropriate antibiotic would be available later that day
- a machine is envisaged in which a sample from a patient is divided into x samples and each sample is incubated to provide about 10 5 cells per sample Each sample is then treated with a different antibiotic and incubation continued After set periods of time the zeta potential of each sample is measured The antibiotic associated with the sample whose zeta potential tends to zero quickest is the treatment of choice.
- a printer associated with the machine can then print out a prescription for checking and signature by the medical practitioner.
- This method is not a method of diagnosis as such. It simply provides the medical practitioner with information on which agent(s) kills the micro-organism(s) most satisfactorily in vitro. It can be carried out by a technician with no medical knowledge and only basic training.
- the invention may be applied to assessing emerging drugs for antimicrobial activity.
- the invention can be applied to screening for agents having antimicrobial activity.
Abstract
A method of identifying one or more micro-organisms in a fluid comprising the steps of: (i) taking a sample of the fluid containing a representative sample of any micro-organism(s) present; (ii) optionally culturing the sample if necessary to increase the number of micro-organisms for a pre-determined range; (iii) measuring the zeta potentials of any micro-organisms present; (iv) optionally normalising the measurements taken in step (iii) such that they relate to standard conditions; (v) comparing said measured zeta potentials with a table of the zeta potentials of known micro-organisms to determine which, if any, of the known micro-organisms are present in the fluid.
Description
Rapid Method for Detecting Micro-Qrqanisms and Evaluating Antimicrobial
Activity
Field of the Invention The present invention relates to methods and apparatus for the detection of the presence of specific micro-organisms in a fluid It is particularly applicable, but in no way limited, to identifying microbial pathogens in liquid solution The invention also relates to methods for antibiotic sensitivity testing, and in particular methods for assessing the effectiveness of antimicrobial agents, for screening compounds for antimicrobial activity, and for determining an appropriate means of treatment for an unknown microbial infection
Background to the Invention
There are many applications in which it is important to be able to detect the presence of a specific micro-organism For example, in combating viral or bacterial infections, it is necessary to be able to identify the micro-organism responsible Also in the brewing industry, it is important to be able to determine if a yeast is present in a solution and more particularly to determine its vitality and viability In this context the term micro-organism has a broad meaning It encompasses bacteria, viruses and fungi
In both these examples speed of analysis is extremely important For instance, in diagnosis of a medical problem the medical practitioner needs to know what organism is causing the symptoms within hours rather than days The most appropriate treatment can then be started straight away, giving the patient the best chance of a speedy recovery In some cases, such as meningitis rapid and accurate diagnosis is a matter of life and death
Under present arrangements samples are usually sent to a pathology laboratory for culture and subsequent identification By the very nature of the procedure this takes days rather than hours There may be more than one organism present which requires a number of different cultures in different media
It is also known to detect micro-organisms by the use of specific probes that are designed to attach themselves to the micro-organism by covalent bonding and thus to attach a marker to them so that they may be detected by some physical property Unlike the present invention such techniques are slow and can only search for one micro-organism at a time
The use of microelectro-kinetics to study yeast vitality and viability has been described by P Brown in Brewer's Guardian, November 1997, pages 39-40 However, yeasts are relatively large and particularly uniform in size Even so, it proves difficult to distinguish between commercial yeasts, such as S cerevisiae and S carlsbergensis, and wild yeast Such a result mitigates against being able to differentiate between much smaller organisms such as bacteria which are much more variable in size and shape In fact, zeta potentials of living organisms are poorly understood The method is generally considered tedious, difficult and temperamental Furthermore, it is not readily amenable to multiple sampling Similarly, when treating bacterial infections, it is important to determine whether or not the causative micro-organism is susceptible to the chosen drug or antibiotic However, present techniques for assessing the efficacy of a drug or antibiotic against a particular micro-organism can take several days to carry out Current practice is to prescribe a general or best guess antibiotic to combat the symptoms of the infection In other words therapy of the infection begins before laboratory results are available, and antibiotic sensitivity testing provides only a
supplementary role in confirming that the organism is susceptible to the current agent that is being used Usually the laboratory report will influence treatment only if the patient is failing to respond Sometimes it may allow the clinician to change from a toxic to a less toxic agent Antibiotic sensitivity testing may be defined as a method for determining the sensitivity of a micro-organism to a potential drug treatment The micro-organism may be a bacterium, a fungus, a yeast, a parasite or a virus
Currently the antibiotic sensitivity of bacteria can be assessed in a variety of ways 1 Agar Diffusion tests, in which the antibiotic is allowed to diffuse from a point source, commonly in the form of a filter paper disc, into an agar medium which has been seeded with a test organism
2 Broth dilution tests, in which serial dilutions of antibiotic in a suitable fluid medium are inoculated with the test organism The highest dilution of the antibiotic to inhibit growth after overnight incubation is the minimum inhibitory concentration (MIC)
3 Agar incorporation tests, which are essentially similar to broth dilution tests except that the antibiotic dilutions are incorporated in an agar medium in a series of Petπ dishes These are spot-inoculated with a number of test organisms, usually be means of a semi-automatic inoculation device
These methods, none of which are rapid, are described in detail in Antimicrobial Chemotherapy, edited by David Greenwood, published by Bailliere Tindall, London, pp 73 - 82, and incorporated herein by reference in its entirety
Newer methods of assessing bacterial susceptibility to antibiotics are being developed the most rapid are tests which detect resistance to β-lactam antibiotics
by the demonstration of β-lactamase in bacteria. This can be accomplished in a few minutes once a bacterial culture is available. However, since a wide range of β- lactamases are encountered to which various β-lactam agents display differential susceptibility, the tests are of limited value Other methods employ turbidometπc techniques to detect antibacterial activity by comparing the growth of bacteria exposed to antibiotic with a drug-free control over a time span which for fast growing organisms can be as little as 2 or 3 hours. Turbidometric results show discrepancies with more traditional methods with certain bacterium/drug combinations and there is controversy over the correct interpretation of these results.
Equivalent methods are available for viruses, fungi and other parasites. Clearly, current approaches are less than ideal, and a rapid method for determining antibiotic susceptibility which can be widely applied and which provides results consistent with those obtained by conventional methods is highly desirable. One of the first steps in drug discovery is to find one or more compounds that show a particular biological activity of interest. These first compounds, called leads, are usually discovered by screening, which means testing tens of thousands of random molecules for signs of activity.
Recent developments in automation have made it possible to screen tens of thousands of compounds per month, an effort that would have taken years previously. This has meant that there has been an exploding demand for "libraries" of random molecules to test. Similar developments in automation and combinatorial chemistry have made it possible to synthesise thousands of distinct compounds per month, with a relatively small investment These combinatorial libraries are made by forming all possible combinations of a series of sets of precursor molecules, and applying the same sequence of reactions to each combination The distribution of
precursors, and often the maintenance of reaction conditions, is carried out by a robotic synthesis system
Lead molecules are typically only weakly active, and may be toxic or otherwise unsuitable for use as drugs The next step in drug discovery is lead expansion, in which hundreds or thousands of variants of the most promising leads are made These are tested, and some are typically found to be more active and/or less toxic than the original leads This process can be iterative The combinatorial library approach is also suitable for this lead expansion phase
It is an object of the present invention to provide apparatus and methods which overcome some or all of these disadvantages
Summary of the Invention
According to the present invention there is provided a method of identifying one or more micro-organisms in a fluid comprising the steps of - (i) taking a sample of the fluid containing a representative sample of any mιcro-organιsm(s) present, (n) optionally cultunng the sample if necessary to increase the number of micro-organisms for a pre-determined range, (MI) measuring the zeta potentials of any micro-organisms present, (iv) optionally normalising the measurements taken in step (in) such that they relate to standard conditions, (v) comparing said measured zeta potentials with a table of the zeta potentials of known micro-organisms to determine which, if any, of the known micro-organisms are present in the fluid By way of example there is provided a method of determining the presence of a specific micro-organism in a liquid solution which comprises applying an
electric field across the solution, optically measuring the speed of movement of any micro-organism suspended in the solution as a result of the applied electric field, and identifying the presence of one or more specific organisms by comparing the measured values with those of known micro-organisms which have been measured under standard conditions
The measured speed of movement or electrophoretic mobility is an indication of the electro-kinetic potential, also termed zeta potential, of the micro-organism and is dependent upon several physical properties of the micro-organism including size, shape, overall charge and surface charge distribution As well as permitting a solution to be analysed for the presence of a specific micro-organism, by comparing the zeta potentials measured during analysis of a solution with a table of the zeta potentials of known micro-organisms, the invention can enable rapid analysis of a solution to determine what mixture of microorganisms are present According to a second aspect of the invention, there is provided an apparatus for determining the presence of a specific micro-organism in a liquid solution which comprises means for applying an electric field across a measurement cell containing the solution, a laser light source for illuminating the cell, detecting means for sensing light after impinging on a micro-organism suspended in the solution, means for analysing the scattered light to provide a measurement of the speed of movement of the micro-organism by which the laser light was scattered, and means for identifying the presence of the specific micro-organism upon measurement of a speed of movement matching that of the micro-organism
The apparatus of the invention, as well as distinguishing between micro- organisms on the basis of their electo-kinetic potential, achieves improved sensitivity by allowing the scattering angle at which light is detected to be optimised for the
micro-organism of interest as it has been found in practice that light from different micro-organisms is scattered in different directions
It is preferred for the laser light source to comprise a laser, a beam splitter for dividing the light emitted from the light source into two coherent beams, means for directing the light beams along different directions and means for modulating the length of one of the light paths to create a variable interference pattern between the two beams at the cell The effect of modulating the length of one of the light paths will be that the interference pattern will oscillate along the cell and light scattered by a stationary particle or micro-organism will pulsate at the frequency of the modulation If the particle is moving however, it will move with the interference in one direction and in opposition to it in the opposite direction Because of the Doppler effect, the frequency of modulation of the scattered light will differ from the frequency of modulation of the length of one of the light paths by an amount indicative of the rate of movement of the particle in the cell The detected frequencies of light scattered by moving particles when the applied electric field is reversed should be symmetrical about the modulation frequency of the light path If, however, the electrodes of the cell are polarised then reversal of the potential applied to the electrodes will not result in an exact reversal of the applied electric field and the measurements obtained will not be symmetrical It is preferred to provide means for reversing the polarity of the electric field applied across the cell periodically to avoid polarisation of the electrodes as a result of an electrolytic reaction between the electrodes and ions in the solution
The speed with which a given micro-organism will move through a solution when an electric field is applied will depend on certain factors other than the zeta potential, such as the pH and temperature of the solution It is preferred to maintain
these factors constant during measurement but it is alternatively possible to measure these parameters and compensate the measurement obtained
According to a third aspect of the present invention there is provided a method of identifying the cause of an infection in a human or animal body comprising the steps of -
(a) removing a sample from the body such as a urine sample,
(b) cultuπng the sample if necessary to increase the number of microorganisms to a pre-determined range,
(c) measuring the zeta potential of said micro-organisms using the method described herein,
(d) comparing the measured zeta potentιal(s) with values obtained on isolated micro-organisms
This method can be used to direct a physician to an appropriate course of treatment For example, not only can the method flag up the infecting species, but it can also list a range of possible drug treatments known to be effective against the micro-organisms which have been identified The physician would then select the appropriate treatment based on this information, the symptoms exhibited by the patient and the physicians skill and experience
According to a further aspect of the invention there is provided a method for antibiotic sensitivity testing
In one embodiment, the method comprises
(a) measuring the zeta potential of one or more micro-organism in a sample,
(b) adding to said sample an antimicrobial agent
(c) measuring again the zeta potential of the said one or more microorganisms in said sample,
(d) determining the change in zeta potential between said measurements and correlating said change to either
(i) the antimicrobial sensitivity of said one or more microorganisms in said sample, or
(II) the antimicrobial activity of said antimicrobial agent
In a further embodiment, the step correlating said change in zeta potential to either the antimicrobial sensitivity of a micro-organism or to the antimicrobial activity of a an antimicrobial agent may be automated
The present invention enables the following objectives and advantages to be accomplished
It is an object of the present invention to provide a method for rapidly assessing the susceptibility of a patient or veterinary sample to a spectrum of antimicrobial agents in order to determine the most appropriate treatment to be initiated Advantages of the present invention include avoidance of the development of drug-resistant strains, economic dispensing of medicines, and an increase in the quality of patient care
Another object of the present invention is to provide a method for assessing emerging drugs for antimicrobial activity Advantages of the present invention include determination of MIC values, investigation of the effects of the candidate drugs on microbial physiology, and determination of the mechanism of action of the candidate drug
A further object of the present invention is to provide a method for screening for agents having antimicrobial activity. Advantages of the present invention include the ability quickly to perform large-scale, automated screening; to identify drugs which affect cell vitality but not cell viability. A yet further object of the present invention is to provide an automated method for screening agents for antimicrobial activity.
Description of the Drawings
The invention will be further described, by way of an example only, with reference to the accompanying drawings wherein:-
Figure 1 illustrates a stylised diagram of a yeast cell; Figure 2 illustrates graphically the diffuse double layer around a sphere of moderate potential;
Figure 3 illustrates schematically a typical double beam apparatus for measuring zeta potentials;
Figure 4 shows the Zeta potential profile of a control sample of S pneumoniae;
Figure 5 shows the zeta potential profile of a sample of S pneumoniae treated with penicillin.
Description of the Preferred Embodiments
The present aspects and embodiments represent currently the best ways known to the applicant of putting the invention into practice. But they are not the only ways in which this could be achieved. They are illustrated, and they will now be described, by way of example only.
Techniques and apparatus for measuring electrophoretic mobility and zeta potential are known per se and have been used in the analysis of certain colloidal suspensions, such as paints The present invention is, however, based on the discovery that the zeta potential of a micro-organism is a parameter which under properly controlled conditions, can act as a reliable indicator of the presence of that specific micro-organism
Microelectrophoresis is a division of the science of electrophoresis and deals specifically with particles in the region of less than 20 μm and with a minimum dimension in the order of 0 01 μm Below this limit, objects are considered to be of molecular dimensions There is considerable blurring of this lower border especially when dealing with macromolecules Electrophoresis has long been the method of choice for identifying many charged molecular species, such as proteins, nucleic acid and ammo acids One much publicised type of electrophoresis is DNA finger printing which allows the separation and matching of two samples of DNA Micro-organisms of all types, from bacteria to viruses fall into the size range applicable to microelectrophoresis Viruses are particularly interesting because they are composed mostly of protein and nucleic acid and tend to have a relatively stable, uniform structure As such, they provide a direct link with conventional electrophoresis techniques When any surface is placed in contact with an aqueous solution the surface acquires a surface charge which is usually negative The origins of this are either absorption of ions from solution or by the lonisation of charged groups on the surface In the case of micro-organisms both of these mechanisms can be seen to operate and the observed surface charges are usually negative, which is the commonly observed sign The use of this charge to identify specific microorganisms is what makes this technology both novel and powerful Importantly, the
method is not size dependent so both large and small micro-organisms can be identified
For purposes of microelectrophoresis Figure 1 describes how the microorganisms can be regarded from this view point The shaded areas represent areas of hydrophobic surface at which charge builds up at the surface through contact absorption Also shown at this surface are the charges native to the surface of the micro-organism and specifically absorbed at the surface. The charge produces an electrical double layer and the electrical potential varies as described by Figure 2. Fig. 2 shows the distribution of charge across a double layer at the surface of a hypothetical micro-organism. The charge at the shear surface is the zeta potential; beyond this the charge decays away rapidly in the bulk solution.
The surface charge of an idealised micro-organism arises from two sources.
First groups on the surface of the micro-organism, such as carboxylate groups, may be ionised. Secondly, ions may be adsorbed from solution onto the surface of the micro-organism, particularly at hydrophobic regions on the surface where anionic groups may be preferentially adsorbed.
Apparatus for measuring zeta potentials are known per se. One such example is the ZETASIZER 2000 (TM) made by Malvern Instruments.
This instrument, as it name suggests, is used to measure particle size. It utilises a dual laser beam and a photodetector is arranged to measure deflected light at a fixed scattering angle.
A typical double beam instrument is shown in Figure 3 which illustrates a neon-helium laser 10 producing a red laser beam The beam is incident upon a beam splitter 12 that allows half the incident light energy to pass through it towards a mirror and modulator 1 and reflects the other half towards a mirror 18. The mirror and modulator 14 is a mirror vibrated by a piezoelectric vibrator that reflects the
incident beam towards a further stationary mirror 16 The two halves of the split laser beam are focused by a lens 20 an a cell 22 that contains a liquid to be analysed An electric field that is reversed periodically is applied across the cell by means of electrodes 22 and 24 and this causes micro-organisms in the liquid to move with a characteristic velocity towards the electrode that instantaneously has the opposite polarity to the net charge on the micro-organism When the microorganism is illuminated by the laser light it scatters the incident light in a predetermined direction and this light is sensed by means of a detector 26
The two halves of the split laser beam travel different distances before reaching the cell 20 In the case of the half that is reflected by the mirror and modulator 14, the path length is modulated periodically When they are recombined, the two halves of the split laser interfere with one another and the interference pattern will move across the cell As a result, a stationary particle suspended in the cell will scatter light at a frequency related to the frequency of modulation of the mirror 14 If, however, a particle is moving towards one end of the ceil 20 or the other, then while it is moving with the interference pattern, light scattered from it will have a lower frequency and conversely when the particle is moving in the opposite direction to the interference pattern light scattered from it will have a higher frequency By analysing the frequency of the scattered light sensed by the detector 26 it is possible to determine the speed and direction of movement of the particle
The speed of movement is related to the distribution of charge about the surface of the particle and is indicative of the so-called zeta potential Depending on the shape of the particle, it will align itself differently in the applied electric field and for any specific micro-organism there will be an angle at which the intensity of the scattered light is a maximum The apparatus may therefore be used to determine the presence of a specific micro-organism in the solution being analysed by setting
the detector 26 to the scattering angle associated with the micro-organism and monitoring the output of the detector for the frequencies corresponding to the previously determined speed of movement of the micro-organism in the applied field It is preferred to take steps to prevent polarisation of the electrodes 22, 24 as such polarisation may affect the electric field as sensed by particles suspended in the liquid in the cell 20. Polarisation may be prevented by peπodically switching the polarity of the electric field. Such switching will in itself prevent polarisation but additionally it will allow polarisation to be detected as the detected frequencies will not be symmetrical about the frequency of movement of the bands of the interference pattern.
The detector type used in this application can take a number of forms. However, we have found that commercially available solid state photodiodes such as Radio Spares Model AEPX 65 (Stock No 846/749) work well. The nature of the data captured takes the form of a senes of exponential decays These represent the length of time taken for the scattered light to decay to zero, this is effectively the particle velocity The exponential decays are converted to mean normal distributions. These are collected and transformed graphically by the method of Eishus to give mobilities and zeta potentials as follows:- t m g( )(t) = 2 sinh ( AT) Σ G, exp (-tr)
g(1)(t) = normalised electric field autocorrelation function G, = normalisation constants and are obtained from fitting experimental values of r to the summation part of the above equation Values of j are usually limited to 3 and are identified with the mean, standard deviation and skewness of the data
For the homodyne case the g(1)(t) is obtained from: g(2)(t) = 1 + [g(1)(t)]2 where g(2)(t) is obtained from
g( )(t) = 1 + e r and is known as the homodyne autocorrelation coefficient
(Ref. D.E. KOPPEL J Chem Phys 1972 57 4814)
This method of handling the data measured is contained in a software programme as a means for analysing the scattered light. In addition, the software can contain a library or table of recorded measurements for known micro-organisms. A comparator programme can be run such that the operator receives as a print-out or screen message a list of those micro-organisms considered to be present
In this context the term look-up table is used as a generic term to encompass any compilation of zeta potential measurements obtained for known microorganisms. This look-up table can take a variety of forms. It may, for example, be a physical table whereby comparisons are made manually Alternatively, and preferably, the "table" can be a computer database of results. A comparator programme then compares a measured value, or series of measured values, against known results Limits may be included within the programme such that a "best fit" only answer is provided or a range of "possibilities" can be given The comparator programme may also advantageously contain the necessary calculations to normalise the measured zeta potential values such that they relate to standard conditions An apparatus of the general type described above has been used to measure the electrophoretic mobility and zeta potentials of known micro-organisms. The machine was calibrated using a standard NaCI solution having a conductivity of 0.15mS and a pH of approximately 7 0 Test samples were normalised to this conductivity by use of the Bπggs equation, which in this case takes the form
Where the K's are solution, observed and standard respectively
Most encouragingly, different samples of the same bacteria gave constant results. Unexpectedly, the zeta potential peaks for different organisms occurred at different and distinguishable voltages The sensitivity of the present system is such that different organisms can be identified uniquely, even from a mixture of organisms. Typical results are shown in Table 1. This work shows how microorganisms can be identified one from another in dilute aqueous solution at pH7. These experiments were carried out by injecting a solution containing in the region of 100,000 micro-organisms per millilitre into an apparatus as shown in Figure 3 or an apparatus of the type described above.
TABLE I
TABLE I (Contd)
It is assumed that the data is normally distributed around the mean, which has been established for yeasts in normal growth This allows calculation of the goodness of separation which in this case it is represented by the chi squared analysis shown in Table II.
TABLE II Chi sguared analysis of date in Table I
0 Table II indicates that the only two members of the table that are not separable are the two members of the listeπa group of organisms.
The observation that two different strains of the Listeπa bacteria cannot be differentiated one from another does not greatly detract from this method The information that a patient is suffering from Listenosis, as opposed to an E Coli or 5 other bacterial infection, is of great assistance to a medical practitioner A course of
treatment can be started immediately which will combat all Listeπa strains which are commonly found in the human population
However, it is possible to further enhance the sensitivity of this method by incorporating one or more of the additional steps, which make the identification process more discπminatory, or provide confirmation of micro-organism identity
1 Cultuπng the sample in a medium selective for a particular micro-organism or class of micro-organisms, whereby the micro-organism or micro-organisms of interest grows in preference to other micro-organisms that may be present A wide range of selective media is available from Oxoid Ltd and is described in their catalogue This provides a method of distinguishing between micro-organisms that otherwise have very similar zeta potentials
2 Contacting the sample with an agent known to kill one or more of the microorganisms present, and measuring the zeta potential a second time The elimination of the zeta potential corresponding to the micro-organism of interest is a confirmatory test if the agent is specific for the micro-organism of interest The agent may be an antibiotic, antibacterial or other selective poison The same end may also be accomplished by contacting the sample with an agent that specifically causes the agglomeration of the microorganism, such as an antibody or other immunological reagent, whereby the micro-organism is precipitated out of solution
3 Measuring the zeta potential at a second pH and comparing said zeta potential with a second table of the zeta potentials of known micro-organisms at this second pH The diversity of the ionising groups on the surface of the micro-organism, which contribute to the zeta potential, means that a distinction can be made between two micro-organisms which have a similar zeta potential at one pH, but not at another
The facility to perform zeta potential measurements at different pH's is a key aspect of one of the embodiments of the invention It provides a means of distinguishing between two micro-organisms which would otherwise be difficult or impossible to separate. In one embodiment this process can be automated. Having taken a zeta potential measurement at a first pH, an aliquot of acid or base can be introduced into the measurement cell and the reading repeated. In fact, a series of pH's can be used by the incremental additions of acid or base
Dosage means to infect a solution of acid or alkali is known per se to the person skilled in the art Typical bases which can be used are sodium or potassium hydroxide or an amine base such as tnethylamine Acids include hydrochloric or sulphuric acid or organic acids such as acetic or citric acid.
The apparatus may advantageously include a pH meter such that the pH of the solution in the cell is measured and recorded automatically. The uniformity of virus structures would give every indication that viruses can be distinguished one from another in a similar way
As such, this method represents an important new method of diagnosis which can be performed in vitro on a sample removed from the human body The method does not have to be performed by a medical practitioner but can be readily carried out by a technician. The technician need not have any medical knowledge in order to carry out this method effectively and requires only the most basic of training
The method provides the medic with a clear indication of which pathogenic bacteria, or combination of bacteria, are present in the patient's sample From that information and the symptoms experienced by the patient, the medic can then
formulate the most appropriate treatment It provides, in effect, an intermediate result upon which to decide on a suitable course of treatment
Except as stated above, it is preferred that the pH value of the solution and its temperature should always be the same during measurement as the pH may affect the measured zeta potential but it is alternatively possible to compensate the obtained measurement for changes in pH and temperature
However, an important advantage of the present invention is that while the chemical composition of the micro-organism is the same whether it is alive or dead, the zeta potential changes when the micro-organism dies because the charge distributed around the micro-organism is affected by the chemical processes taking place while the organism is alive, especially near its outer periphery If, therefore, steps have been taken to eliminate a micro-organism that is the cause of an infection, the present invention can be used to determine if such steps have been effective The invention has been described in relation to identifying organisms in a solution In this context the term "solution" has a very broad meaning It refers to any liquid, organic or inorganic, which may contain a micro-organism It includes, by way of example only, notionally pure water, brewing worts, body fluids such as urine and diluted samples of these, plant extracts or swabbings and solutions obtained by bubbling a gas through a liquid in order to entrain any micro-organisms present in the gas In this way contaminations in gaseous fluids may also be investigated using the present method
This method is not limited to the foregoing micro-organisms in Table I Potentially any pathogenic micro-organism or class of micro-organism can be identified using this method and the preferred treatment(s) selected
Where very small numbers of bacteria are present in the initial sample then it may be necessary to culture the micro-organism using methods well-known in the art
The bacterial count in the urine from patients having urinary infections is in the order of 106 to 107 cells per ml These levels are easily and rapidly detected using the method of the present invention, and it is anticipated that an indication of the infecting pathogen will be provided within 5 minutes
Food and water samples however tend to contain rather fewer bacteria per ml, and for these the sample will need to be cultured The sample may be mixed with, for example, McConkey's broth After a predetermined time, when the number of cells present per ml will have increased to 105 or more, the cultured sample may be analysed for the presence or absence of micro-organisms using the method of the present invention No filtration is necessary and the broth ingredients do not interfere with the analysis Food samples are prepared, for example, by swabbing the surface of the food or macerating the food Thus Salmonella could be detected in a chicken neck flap swab within 7h, and indications are that 200 cells per ml of Salmonella (a level which is considered to be infective) could be detected within 2 5h culture time
These timescales contrast markedly with the methods currently available where results take days not hours to come through Recent food poisoning and meningitis scares have shown that patients can deteriorate very substantially or even die over this time period Providing there are sufficient micro-organisms in the sample then a result can be obtained in minutes using the present method Importantly, the culture media used to multiply micro-organisms do not interfere so no filtration or only crude filtration is required
This method, and particularly the method of data processing is applicable to a wide variety of samples including human and animal body fluids, plant extracts, food, drink and notionally pure water
In a further aspect of the invention, this method can be applied to provide a method of antibiotic sensitivity testing The method comprises measuring the zeta potential of a microbial sample, which may be a known micro-organism or a clinical or veterinary sample, the sample is then exposed to an antimicrobial agent, subsequent measurement of the zeta potential indicates both the potency of the antibacterial material, and the sensitivity of the microbial sample to that material In another embodiment, the approach may be applied to assessing the antimicrobial activity of a mateπal Without wishing to limit the scope of the invention, the material may be a compound or mixture of compounds isolated from a natural source, it may be a compound that is a derivative of a known family of antimicrobial agents, or it may be one or more compounds from a library of compounds produced by combinatorial chemistry techniques Typically these libraries contain between 5 and 50 variants of a candidate therapeutic agent
In a further embodiment, the approach may be applied to determining the antimicrobial susceptibility of a clinical or veterinary sample obtained from a patient or animal suspected of suffering from a microbial infection to determine the most effective treatment of the infection
The following Example illustrates a particular embodiment of the invention Streptococcus pneumoniae was grown for about 4 h in iaked horse blood medium Ahqouts, representing about 105 cells, were transferred to two tubes containing growth medium one of these also contained penicillin at 0 01 g/ml The zeta potential of both samples was measured using a ZETASIZER 2000 (RTM) from Malvern Instruments The tubes were incubated at 37°C for 3 h, and the zeta
potential of each measured again Figure 4 shows the zeta potential profile of the tube containing the growth medium and S pneumoniae only Figure 5 shows the zeta potential of the tube additionally containing penicillin There is a clear difference in these profiles In both Figures, the peak at 0 mV represents dead cells The zeta potential of all dead micro-organisms is close to 0 mV without wishing to be bound by a particular theory, it is believed that these changes are brought about by the vacuolation of the cells, resulting in the zeta potential decaying to about 0 mv Living, healthy cells of S pneumoniae have a zeta potential of about -27 9 mV, as shown in Fig 4 and Table III The other peak in Fig 4 is believed also to be cells of S pneumoniae, but which are non-viable
Table III. Mean Zeta Potentials for S pneumoniae
Thus the present invention is directed toward a method for assessing antimicrobial sensitivity In one aspect, the invention provides a method for rapidly assessing the susceptibility of a patient or veterinary sample to a spectrum of antimicrobial agents in order to determine the most appropriate treatment to be initiated This process could be automated, so that a patient would have a sample taken during the morning by a nurse or technician, the sample would be analysed according to the present invention, and a prescription for the most appropriate antibiotic would be available later that day
A machine is envisaged in which a sample from a patient is divided into x samples and each sample is incubated to provide about 105 cells per sample Each sample is then treated with a different antibiotic and incubation continued After set periods of time the zeta potential of each sample is measured
The antibiotic associated with the sample whose zeta potential tends to zero quickest is the treatment of choice. A printer associated with the machine can then print out a prescription for checking and signature by the medical practitioner.
This method is not a method of diagnosis as such. It simply provides the medical practitioner with information on which agent(s) kills the micro-organism(s) most satisfactorily in vitro. It can be carried out by a technician with no medical knowledge and only basic training.
In another aspect the invention may be applied to assessing emerging drugs for antimicrobial activity. In a further aspect the invention can be applied to screening for agents having antimicrobial activity.
The foregoing describes how the approach may be used for antibacterial agents: the same approach may be applied to antifungal, antiviral and anti-parasitic agents.
Claims
1 A method of identifying one or more micro-organisms in a fluid comprising the steps of - (i) taking a sample of the fluid containing a representative sample of any mιcro-organιsm(s) present, (n) optionally cultuπng the sample if necessary to increase the number of micro-organisms for a pre-determined range, (in) measuring the zeta potentials of any micro-organisms present, (iv) optionally normalising the measurements taken in step (in) such that they relate to standard conditions, (v) comparing said measured zeta potentials with a table of the zeta potentials of known micro-organisms to determine which, if any, of the known micro-organisms are present in the fluid
2 A method according to Claim 1 wherein a first zeta potential measurement is obtained on a fluid sample at a first pH and a second zeta potential measurement is obtained at a second pH, the difference, if any, between the first and second measurements being used to distinguish between micro-organisms with otherwise similar zeta potentials
3 A method according to Claim 1 or Claim 2 wherein in optional step (u) the sample is cultured in a medium selective for a particular organism or class of organisms, said modification providing a method of distinguishing between micro- organisms that otherwise have similar zeta potentials
4 A method according to any preceding claim wherein in a further step the sample is contacted with an agent known to kill one or more particular micro- organ╬╣sm(s) and measuring the zeta potential a second time, the elimination of the zeta potential corresponding to a micro-organism of interest providing confirmation of its presence
5 A method according to any preceding claim wherein said sample is a sample taken from a human or animal body, said method providing an indication of the cause of an infection in said human or animal body
6 A method according to any preceding claim wherein the comparison between the measured zeta potent╬╣al(s) and said table of known zeta potentials is carried out using a computer programme, the result being displayed on a computer screen or by way of a printout
7 A method of identifying one or micro-organisms in a fluid substantially as herein described with reference to and as illustrated in any combination of the accompanying drawings
8 A method of identifying the cause of an infection in a human or animal body comprising the steps of -
(a) removing a sample from the body such as a urine sample,
(b) optionally cultuπng the sample if necessary to increase the number of micro-organisms to a pre-determmed range, (c) measuring the zeta potential of any micro-organisms present, (d) comparing said measured zeta potentials with a table of the zeta potentials of known micro-organisms to determine which, if any, of the known micro-organisms are present in the fluid.
9. A method according to Claim 8 wherein a first zeta potential measurement is obtained on a fluid sample at a first pH and a second zeta potential measurement is obtained at a second pH, the difference, if any, between the first and second measurements being used to distinguish between micro-organisms with otherwise similar zeta potentials.
10. A method according to Claim 8 or Claim 9 wherein in optional step (b) the sample is cultured in a medium selective for a particular organism or class of organisms, said modification providing a method of distinguishing between microorganisms that otherwise have similar zeta potentials.
11. A method according to any of Claims 8 to 10 wherein in a further step the sample is contacted with an agent known to kill one or more particular micro- organism(s) and measuring the zeta potential a second time, the elimination of the zeta potential corresponding to a micro-organism of interest providing confirmation of its presence.
12. A method according to any of Claims 8 to 11 wherein the comparison between the measured zeta potential(s) and said table of known zeta potentials is carried out using a computer programme, the result being displayed on a computer screen or by way of a printout.
13 A method of identifying the cause of an infection on a human or animal body substantially as herein described with reference to and as illustrated in any combination of the accompanying drawings
14 A method of antibiotic sensitivity testing comprising -
(a) measuring the zeta potential of one or more micro-organism in a sample,
(b) adding to said sample an antimicrobial agent,
(c) measuring again the zeta potential of the said one or more micro- organisms in said sample,
(d) determining the change in zeta potential between said measurements and correlating said change to either
(i) the antimicrobial sensitivity of said one or more microorganisms in said sample, or
(n) the antimicrobial activity of said antimicrobial agent
15 A method of antibiotic sensitivity testing substantially as herein descπbed and with reference to any combination of the accompanying drawings
16 An apparatus for carrying out the methods described in Claims 1 to 15 inclusive comprising -
(i) means for applying an electric field across a measurement cell, (n) a light source for illuminating the measurement cell, (iii) detecting means for detecting light scattered by micro-organisms present in the cell;
(iv) means for analysing the scattered light to provide a measurement of the speed of movement of a micro-organism(s); (v) means for computing the zeta potential of said micro-organism(s);
(vi) means for comparing said measured zeta potentials with the zeta potentials of known organisms.
17. An apparatus as claimed in Claim 16 which further comprises a means for normalising the zeta potential measurements to facilitate comparison with results for known micro-organisms measured under standard conditions.
18. An apparatus as claimed in Claim 16 or Claim 17 wherein the means for comparing measured and reference zeta potentials comprises a comparator computer programme in which the measured value is compared with values in one or more look up tables, the results being displayed on a VDU screen or printed out on a printer.
19. An apparatus substantially as herein described with reference to and as illustrated in any combination of the accompanying drawings.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9806759 | 1998-03-31 | ||
| GBGB9806759.8A GB9806759D0 (en) | 1998-03-31 | 1998-03-31 | Detection of micro-organisms |
| GB9820703 | 1998-09-24 | ||
| GBGB9820703.8A GB9820703D0 (en) | 1998-03-31 | 1998-09-24 | Improved method of detecting micro-organisms |
| GBGB9825222.4A GB9825222D0 (en) | 1998-11-19 | 1998-11-19 | A rapid method for evaluating antimicrobial activity |
| GB9825222 | 1998-11-19 | ||
| PCT/GB1999/001001 WO1999050659A2 (en) | 1998-03-31 | 1999-03-30 | Rapid method for detecting micro-organisms and evaluating antimicrobial activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1068527A2 true EP1068527A2 (en) | 2001-01-17 |
Family
ID=27269268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99914648A Withdrawn EP1068527A2 (en) | 1998-03-31 | 1999-03-30 | Rapid method for detecting micro-organisms and evaluating antimicrobial activity |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1068527A2 (en) |
| JP (1) | JP2002510049A (en) |
| AU (1) | AU3338299A (en) |
| CA (1) | CA2326320A1 (en) |
| WO (1) | WO1999050659A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2363842A (en) * | 2000-02-17 | 2002-01-09 | Zetatronics Ltd | Micro-organism identification |
| GB0010628D0 (en) * | 2000-05-04 | 2000-06-21 | Zetatronics Ltd | Process and apparatus for monitoring and controlling fermentation processes |
| US20100285140A1 (en) * | 2007-12-27 | 2010-11-11 | Shoichi Shirotake | Antimicrobial agent for gram-positive bacteria |
| US20130324437A1 (en) * | 2010-08-12 | 2013-12-05 | The Regents Of The University Of California | Method for identifying antimicrobial compounds and determining antibiotic sensitivity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3722504A (en) * | 1969-12-23 | 1973-03-27 | P Sawyer | Method of screening substances for use in the treatment of circulatory system diseases |
| WO1979000834A1 (en) * | 1978-03-24 | 1979-10-18 | High Stoy Tech | System for analyzing chemical and biological samples |
| CA2097295A1 (en) * | 1991-09-30 | 1993-03-31 | Palitha Jayaweera | Use and selection of coating and surface materials to control surface fouling and corrosion using zeta potential measurement |
-
1999
- 1999-03-30 AU AU33382/99A patent/AU3338299A/en not_active Abandoned
- 1999-03-30 JP JP2000541517A patent/JP2002510049A/en not_active Withdrawn
- 1999-03-30 EP EP99914648A patent/EP1068527A2/en not_active Withdrawn
- 1999-03-30 WO PCT/GB1999/001001 patent/WO1999050659A2/en not_active Application Discontinuation
- 1999-03-30 CA CA002326320A patent/CA2326320A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9950659A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999050659A2 (en) | 1999-10-07 |
| AU3338299A (en) | 1999-10-18 |
| JP2002510049A (en) | 2002-04-02 |
| WO1999050659A3 (en) | 2000-01-20 |
| CA2326320A1 (en) | 1999-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nemati et al. | An overview on novel microbial determination methods in pharmaceutical and food quality control | |
| US7341841B2 (en) | Rapid microbial detection and antimicrobial susceptibility testing | |
| US9657327B2 (en) | Rapid microbial detection and antimicrobial susceptibility testing | |
| EP1831692B1 (en) | Rapid microbial detection and antimicrobial susceptibility testing | |
| CN102203588B (en) | Methods for separation, characterization and/or identification of microorganisms using spectroscopy | |
| David et al. | Viability and membrane potential analysis of Bacillus megaterium cells by impedance flow cytometry | |
| US20020148729A1 (en) | Method for separation, identification and evaluation of microbes and cells | |
| CN110234749A (en) | Analyze and use the motility kinematics of microorganism | |
| Capobianco et al. | Detection of pathogenic bacteria in large volume food samples using an enzyme-linked immunoelectrochemical biosensor | |
| Ren et al. | Rapid detection of antibiotic resistance in Salmonella with screen printed carbon electrodes | |
| US20030022270A1 (en) | Automated epifluorescence microscopy for detection of bacterial contamination in platelets | |
| GB2335981A (en) | Rapid method for detecting micro-organisms | |
| US20040067547A1 (en) | Rapid method for detecting micro-organisms and evaluating antimicrobial activity | |
| EP1068527A2 (en) | Rapid method for detecting micro-organisms and evaluating antimicrobial activity | |
| WO2022241246A1 (en) | Techniques for optimizing detection of particles captured by a microfluidic system | |
| Salzman et al. | Current and experimental methods of rapid microbial identification | |
| RU2180748C1 (en) | Method for quantitatively determining levomycetin in foods and pharmaceutical preparations | |
| EP3740585B1 (en) | Improving detection of microorganisms | |
| Mansour et al. | In Vitro Activity and Atom Pair Fingerprint Analysis of Potent Hits from Malaria Box against Staphylococcus aureus Isolated from Cows with Clinical Mastitis | |
| US20200393377A1 (en) | Microscopy for Rapid Antibiotic Susceptibility Test Using Membrane Fluorescence Staining and Spectral Intensity Ratio | |
| CN108303404A (en) | A method of microorganism is quickly distinguished using conjugated polymer | |
| Lodha et al. | Navigation of medical microbiology to diagnostic microbiology | |
| Salman | Life Science Archives (LSA) | |
| RU2113467C1 (en) | Method of bacterium identification | |
| Orrell-Trigg et al. | Rapid screening of bacteriostatic and bactericidal antimicrobial agents against Escherichia coli by combining machine learning (artificial intelligence) and UV-VIS spectroscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20001026 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20051001 |